title: In vitro metabolism of 19-nor-1alpha, 25-(OH)2D2 in cultured cell lines: inducible synthesis of lipid- and water-soluble metabolites.
abstract: The active vitamin D analog, 19-nor-1alpha,25-dihydroxyvitamin D2 (19-nor-1alpha,25-(OH)2D2), has a similar structure to the natural vitamin D hormone, 1a,25-dihydroxyvitamin D3 (1alpha,25-(OH)2D3), but lacks the C10-19 methylene group and possesses an ergosterol/ vitamin D2 rather than a cholesterol/vitamin D3 side chain. We have used this analog to investigate whether any of these structural features has any effect upon the type and rate of in vitro metabolism observed. Using a vitamin D-target cell, the human keratinocyte, HPK1A-ras, we observed formation of a number of metabolites, three of which were purified by extensive HPLC and conclusively identified by a combination of GC-MS and chemical derivatization as 19-nor-1alpha,24,25-(OH) 3D2, 19-nor-1alpha,24,25,26-(OH) 4D2, and 19-nor-1alpha,24,25,28-(OH)4,D2. The first metabolite is probably a product of the vitamin D-inducible cytochrome P450, P450cc24 (CYP24), while the latter two metabolites are likely to be further metabolic products of 19-nor-1alpha,24,25-(OH)3D2. These hydroxylated metabolites resemble those identified by other workers as products of the metabolism of 1alpha,25-(OH)2D2 in the perfused rat kidney. It therefore appears from the similar metabolic fate of 19-nor-1alpha,25-(OH)2D2 and 1alpha,25-(OH)2D2 that the lack of the C10-19 methylene group has little effect upon the nature of the lipid-soluble metabolic products and the rate of formation of these products seems to be comparable to that of products of 1alpha,25-(OH)2D3 in vitamin D-target cells. We also found extensive metabolism of 19-nor-1alpha,25(OH)2D2 to water-soluble metabolites in HPK1A-ras, metabolites which remain unidentified at this time. When we incubated 19-nor-1alpha,25-(OH)2D2 with the liver cell line HepG2, we obtained only 19-nor-1alpha,24,25-(OH)3D2. We conclude that 19-nor-1alpha,25-(OH)2D2 is efficiently metabolized by both vitamin D-target cells and liver cells.
authors.affiliation: Department of Biochemistry, Queen's University, Kingston, Ontario, Canada.
authors.forename: V N
authors.initials: VN
authors.lastname: Shankar
authors.forename: A E
authors.initials: AE
authors.lastname: Propp
authors.forename: N
authors.initials: N
authors.lastname: Schroeder
authors.forename: B W
authors.initials: BW
authors.lastname: Surber
authors.forename: H L
authors.initials: HL
authors.lastname: Makin
authors.forename: G
authors.initials: G
authors.lastname: Jones
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000737:chemistry / Q000378:metabolism*; D002460:Cell Line; D002851:Chromatography, High Pressure Liquid; D004872:Ergocalciferols / Q000032:analysis / Q000378:metabolism*; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D015603:Keratinocytes / Q000737:chemistry / Q000166:cytology / Q000378:metabolism*; D008055:Lipids / Q000737:chemistry; D015394:Molecular Structure; D012821:Silanes; D012995:Solubility; D014297:Trimethylsilyl Compounds; D014807:Vitamin D / Q000031:analogs & derivatives / Q000032:analysis / Q000096:biosynthesis
chemical_list: C426835:19-nor-1,24,25,26-tetrahydroxyvitamin D2; C426834:19-nor-1,24,25,28-tetrahydroxyvitamin D2; C426833:19-nor-1,24,25-trihydroxyvitamin D2; D004872:Ergocalciferols; D008055:Lipids; D012821:Silanes; D014297:Trimethylsilyl Compounds; D014807:Vitamin D; C073196:tetramethylsilane; C084656:paricalcitol